Myeloma Patients Europe (MPE) shared a post on LinkedIn:
“Day 3 of EHA 2026 starts bright and early with MPE’s Head of Patient Research Eilidh Duncan joined leading haematologists Monique Minnema, Fredrik Schjesvold and Meletios Athanasios Dimopoulos to discuss shared decision-making in myeloma treatment and care.
Eilidh presented MPE’s data and highlighted the need for transparent conversations that include offering meaningful involvement of patients in important decisions about their care.
Find out more about MPE’s research here: Patient Evidence.”
Other articles featuring MPE on OncoDaily.
